Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6330648rdf:typepubmed:Citationlld:pubmed
pubmed-article:6330648lifeskim:mentionsumls-concept:C0018483lld:lifeskim
pubmed-article:6330648lifeskim:mentionsumls-concept:C0002435lld:lifeskim
pubmed-article:6330648lifeskim:mentionsumls-concept:C0002680lld:lifeskim
pubmed-article:6330648lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:6330648lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:6330648pubmed:issue5lld:pubmed
pubmed-article:6330648pubmed:dateCreated1984-8-17lld:pubmed
pubmed-article:6330648pubmed:abstractTextMecillinam, an antibiotic of the beta-lactam group, is active against Gram negative bacilli, with the exception of a few species such as Haemophilus influenzae. The activities of ampicillin, mecillinam, and ampicillin-mecillinam combinations at ratios of 1/1, 2/1, 4/1, 1/2 and 1/4, on 21 Haemophilus influenzae strains, were studied by agar dilution and determination of minimal inhibitory concentrations (MIC). Ampicillin at concentrations of 0.12 to 0.25 mg/l was active on susceptible strains. Beta-lactamase-producing strains were inhibited by 4 and 8 mg/l ampicillin. MICs of mecillinam were above 128 mg/l for 19 strains; two strains were susceptible to 2 mg/l. In every case, antibacterial activity was greater with the ampicillin-mecillinam combination than with either one of the antibiotics alone. The maximum antibacterial effect was obtained at ratios of 1/1 and 1/2; in this case, susceptible strains were inhibited by 0.06 mg/l ampicillin. Kinetic evaluation (killing curves) showed that ampicillin has a bactericidal effect at concentrations under the MIC when it is combined with mecillinam at a 1/1 ratio.lld:pubmed
pubmed-article:6330648pubmed:languagefrelld:pubmed
pubmed-article:6330648pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6330648pubmed:citationSubsetIMlld:pubmed
pubmed-article:6330648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6330648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6330648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6330648pubmed:statusMEDLINElld:pubmed
pubmed-article:6330648pubmed:monthMaylld:pubmed
pubmed-article:6330648pubmed:issn0369-8114lld:pubmed
pubmed-article:6330648pubmed:authorpubmed-author:DelmasCClld:pubmed
pubmed-article:6330648pubmed:authorpubmed-author:LarengM BMBlld:pubmed
pubmed-article:6330648pubmed:authorpubmed-author:DabernatHHlld:pubmed
pubmed-article:6330648pubmed:issnTypePrintlld:pubmed
pubmed-article:6330648pubmed:volume32lld:pubmed
pubmed-article:6330648pubmed:ownerNLMlld:pubmed
pubmed-article:6330648pubmed:authorsCompleteYlld:pubmed
pubmed-article:6330648pubmed:pagination378-80lld:pubmed
pubmed-article:6330648pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6330648pubmed:meshHeadingpubmed-meshheading:6330648-...lld:pubmed
pubmed-article:6330648pubmed:meshHeadingpubmed-meshheading:6330648-...lld:pubmed
pubmed-article:6330648pubmed:meshHeadingpubmed-meshheading:6330648-...lld:pubmed
pubmed-article:6330648pubmed:meshHeadingpubmed-meshheading:6330648-...lld:pubmed
pubmed-article:6330648pubmed:year1984lld:pubmed
pubmed-article:6330648pubmed:articleTitle[Inhibitory activity of ampicillin and mecillinam on Haemophilus influenzae].lld:pubmed
pubmed-article:6330648pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6330648pubmed:publicationTypeEnglish Abstractlld:pubmed